11 – 20 of 124
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
(
- Contribution to journal › Article
-
Mark
The human melanoma proteome atlas-Defining the molecular pathology
(
- Contribution to journal › Article
-
Mark
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
(
- Contribution to journal › Article
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
(
- Contribution to journal › Article
-
Mark
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
(
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
(
- Contribution to journal › Article
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
(
- Contribution to journal › Article
-
Mark
Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset Breast Cancer : A Population-Based Study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article